MIRA INFORM REPORT
|
Report
Date : |
16.01.2007 |
IDENTIFICATION
DETAILS
|
Name : |
IMMUNOSHOP INDIA PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
309, Raheja Arcade, Sector 11, CBD Belapur, Mumbai 400614,
Maharashtra |
|
|
|
|
Country
: |
India |
|
|
|
|
Financials
(as on) : |
-- |
|
|
|
|
Date
of Incorporation : |
August 2004 |
|
|
|
|
Com.
Reg. No.: |
147178 |
|
|
|
|
CIN
No.: [Company
Identification No.] |
U33110MH2004PTC147178 |
|
|
|
|
TAN
No.: [Tax
Deduction & Collection Account No.] |
MUMI06731E |
|
|
|
|
Legal
Form : |
Private limited liability company |
|
|
|
|
Line of
Business : |
Marketing and Import of medical Diagnotics products/life
sciences products and research products. |
RATING & COMMENTS
|
MIRA’s
Rating : |
Ca |
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent.
Repayment of interest and principal sums in default or expected to be in
default upon maturity |
Limited with full security |
|
Maximum
Credit Limit : |
|
|
|
|
|
Status
: |
Moderate |
|
|
|
|
Payment
Behaviour : |
Slow and
delayed |
|
|
|
|
Litigation
: |
Unknown |
|
|
|
|
Comments
: |
In absence of latest financials it would be difficult to
assess company’s current performance and financial status. The company’s payments are reported as slow and delayed.
It can be considered for any business dealings on safe and secured trade
terms and conditions, initially. |
LOCATIONS
|
Registered
Office : |
309, Raheja Arcade, Sector 11, CBD Belapur, Mumbai 400614,
Maharastra, India |
|
Tel.
No.: |
91-22-27566891/92/27566990 |
|
Fax
No.: |
91-22-27566893/27565575 |
|
E-Mail
: |
info@immunoshop.com
/ manojmonga@immunoshop.com / neeta@immunoshop.com |
|
Website
: |
DIRECTORS
|
Name : |
Mr. Manoj Monga |
|
Designation
: |
Director |
|
Date
of Birth: |
21.01.1971 |
|
Qualification
: |
M.B.A., M.Sc, Biotechnology |
|
Experience
: |
9 Years |
|
Previous
Employment: |
Profit Centre Head |
BUSINESS DETAILS
|
Line
of Business : |
Marketing and Import of medical Diagnotics products/life
sciences products and research products. |
|
|
|
|
Agencies
Held : |
Ř Biosource Belgium Ř Aeskulab Germany Ř Clinoteck Canada Ř Novatec Germany Ř Biotecx USA Ř Immunoconcepts USA |
|
|
|
|
Exports
to : |
Sells Locally |
|
|
|
|
Imports
from : |
USA, Germany, Canada and Belgium |
|
|
|
|
Terms
: |
|
|
Selling : |
Credit (75-120 days) |
GENERAL INFORMATION
|
Customers
: |
Hospitals, Laboratories, Wholesalers, Research Institutes,
Government Bodies, Individuals, End Users |
|
|
|
|
No. of
Employees : |
34 |
|
|
|
|
Bankers
: |
Jankalyan Bank Vashi Sarsawat Bank |
|
|
|
|
Facilities : |
Cash Credit Limit- Jankalyan Bank Vashi Over Draft - Sarsawat Bank |
|
|
|
|
Banking Relations : |
Unknown |
|
|
|
|
Auditors
: |
S. P. Singh and Partners Chartered Accountants |
|
Address: |
403A, Wing Liberty Apartments, Sector 17, Vashi, New
Mumbai |
FINANCIAL DATA
[all figures are in Rupees Millions]
During several approaches, Ms. Tejashri [Production Manager]
declined business details when Mr. Manoj Monga, Managing Director expected to
resume on Friday.
Overall approach of the management remained non cooperative.
LOCAL AGENCY FURTHER INFORMATION
Webdetails are attached herewith:
Subject at Immunoshop are committed to provide
you Best quality Immunodiagnostic products. They have business tie up with leading
manufacturers of diagnostic products from USA and Europe. Apart from
all evaluations and validations of products by the manufacturers, products
marketed by Immunoshop undergo strict internal and external evaluations in
India, before launching to ensure that their customers get the best
international quality products. These high quality products are well supported
by dedicated product support team at corporate office and marketing team
ensuring their customers with excellent service back up all over India.
Career
There are few opportunities available at their at their
corporate office and all over India in their marketing team at various levels
right from entry level to senior management level. We will groom you with
extensive training, and will provide excellent growth opportunities and package
at par with Industry with good performance linked incentives.
If you are team oriented, versatile, and goal-oriented,
Immunoshop can offer you an interesting and challenging opportunity in their
team.
Business Oportunities
At Immunoshop, they work closely with their distributors and
consider them their business partners. Subject are strengthening
their distribution network and opportunities are available in few
un-represented areas.
They are also in process of appointing C&F agents in
major states.
Customer
Service
Subject
at Immunoshop, understand the importance of prompt and reliable service
and support for which Immunoshop team is continuously endeavoring to excel.
Their Network of executives and Distributors are technically
well equipped to provide prompt services and support to their valuable
customers. This is well supported by the product management and customer
support teams at their corporate office.
They have
also Formed a Customer Support Team (CST) at their corporate office and
endeavors to maintain their response time within 24 hours anywhere in India.
CMT REPORT [Corruption, Money
laundering & Terrorism]
The Public
Notice information has been collected from various sources including but not limited
to: The Courts, India Prisons Service, Interpol, etc.
1] INFORMATION
ON DESIGNATED PARTY
No
exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court
Declaration :
No records exist to suggest that subject is or was the
subject of any formal or informal allegations, prosecutions or other official
proceeding for making any prohibited payments or other improper payments to
government officials for engaging in prohibited transactions or with designated
parties.
3] Asset
Declaration :
No
records exist to suggest that the property or assets of the subject are derived
from criminal conduct or a prohibited transaction.
4] Record
on Financial Crime :
Charges or conviction registered
against subject: None
5] Records
on Violation of Anti-Corruption Laws :
Charges or investigation registered
against subject: None
6] Records
on Int’l Anti-Money Laundering Laws/Standards :
Charges or investigation registered
against subject: None
7] Criminal
Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation
with Government :
No
record exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation
Package :
Our
market survey revealed that the amount of compensation sought by the subject is
fair and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on the subject.
CORPORATE GOVERNANCE
MIRA INFORM
as part of its Due Diligence do provide comments on Corporate Governance to
identify management and governance. These factors often have been predictive
and in some cases have created vulnerabilities to credit deterioration.
Our
Governance Assessment focuses principally on the interactions between a
company’s management, its Board of Directors, Shareholders and other financial
stakeholders.
CONTRAVENTION
Subject is
not known to have contravened any existing local laws, regulations or policies
that prohibit, restrict or otherwise affect the terms and conditions that could
be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.31 |
|
UK Pound |
1 |
Rs.86.82 |
|
Euro |
1 |
Rs.57.29 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP
CAPITAL |
1~10 |
- |
|
OPERATING
SCALE |
1~10 |
4 |
|
FINANCIAL
CONDITION |
|
|
|
--BUSINESS
SCALE |
1~10 |
4 |
|
--PROFITABILIRY |
1~10 |
- |
|
--LIQUIDITY |
1~10 |
- |
|
--LEVERAGE |
1~10 |
- |
|
--RESERVES |
1~10 |
- |
|
--CREDIT
LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT
POINTS |
|
|
|
--BANK
CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER
ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT
POINTS |
|
|
|
--SOLE
DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT
ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER
MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
20 |
This
score serves as a reference to assess SC’s credit risk and to set the amount of
credit to be extended. It is calculated from a composite of weighted scores
obtained from each of the major sections of this report. The assessed factors
and their relative weights (as indicated through %) are as follows:
Financial condition (40%) Ownership background
(20%) Payment record (10%)
Credit history (10%) Market trend (10%) Operational size
(10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses
an extremely sound financial base with the strongest capability for timely
payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses
adequate working capital. No caution needed for credit transaction. It has
above average (strong) capability for payment of interest and principal sums |
Large |
|
56-70 |
A |
Financial
& operational base are regarded healthy. General unfavourable factors
will not cause fatal effect. Satisfactory capability for payment of interest
and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall
operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable
& favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse
factors are apparent. Repayment of interest and principal sums in default or
expected to be in default upon maturity |
Limited with full security |
|
<10 |
C |
Absolute
credit risk exists. Caution needed to be exercised |
Credit not recommended |
|
NR |
In view
of the lack of information, we have no basis upon which to recommend credit
dealings |
No Rating |
|